Skip to main content
RedHill Biopharma Ltd. logo

RedHill Biopharma Ltd. — Investor Relations & Filings

Ticker · RDHL ISIN · US7574681034 LEI · 52990034U7FZBKRAOE32 US Manufacturing
Open in API
Filings indexed 993 across all filing types
Latest filing 2016-05-31 Regulatory Filings
Country IL Israel
Listing US RDHL

About RedHill Biopharma Ltd.

https://www.redhillbio.com/

RedHill Biopharma is a specialty biopharmaceutical company focused on the development and commercialization of proprietary, orally-administered, small molecule drugs. The company's primary therapeutic areas of focus are gastrointestinal (GI) diseases, infectious diseases, and oncology. Its key commercial product is Talicia® for the treatment of Helicobacter pylori (H. pylori) infection. RedHill's late-stage clinical development pipeline includes several drug candidates. Among these are Opaganib, a broad-acting, host-directed antiviral and anti-inflammatory agent; RHB-204 for pulmonary nontuberculous mycobacteria (NTM) disease; and RHB-107 (upamostat), an oral serine protease inhibitor. A significant part of its strategy involves developing its assets for pandemic preparedness and as medical countermeasures, emphasizing therapies with viral mutation-resistant properties suitable for stockpiling.

Recent filings

Filing Released Lang Actions
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filing by a foreign private issuer, RedHill Biopharma Ltd., submitted to the SEC. It includes a press release about a presentation at a healthcare conference. The document is short (1857 characters) and primarily serves as a regulatory update rather than a full financial report or detailed presentation. It does not contain financial statements, management discussion, or detailed analysis. Form 6-K filings are typically used for current reports by foreign private issuers and often fall under general regulatory announcements. Therefore, this document fits best under Regulatory Filings (RNS).
2016-05-31 English
FORM 6-K
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a Form 6-K filed with the SEC by a foreign private issuer, RedHill Biopharma Ltd. It contains a Notice of Annual General Meeting of Shareholders and a detailed Proxy Statement for the AGM to be held on June 8, 2016. The content includes proposals to be voted on at the AGM, instructions for shareholders on voting procedures, and proxy solicitation details. There is no financial data or earnings information, nor is it a transcript or a report of financial results. The document is primarily about soliciting votes and providing information related to the AGM. This fits the definition of Proxy Solicitation & Information Statement (PSI). The document length is substantial and contains the full proxy statement, not just an announcement of a report, so it is not RPA or RNS. Therefore, the correct classification is PSI with high confidence.
2016-05-05 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, RedHill Biopharma Ltd., with the SEC. It includes a press release about a National Cancer Institute grant supporting a Phase II study. Form 6-K is used by foreign private issuers to report material information that is not required to be filed on Form 20-F. The document is short (1922 characters) and primarily serves as an announcement of a press release rather than a detailed financial or operational report. It does not contain financial statements or detailed analysis. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2016-05-04 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, RedHill Biopharma Ltd., with the SEC. It includes a press release about a presentation at a partnering summit. The document is short (1880 characters) and primarily serves as a report of a press release rather than containing detailed financial data or comprehensive report content. Form 6-K filings are periodic reports for foreign private issuers to disclose material information but are not annual or quarterly financial reports themselves. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and filings that do not fit other specific categories.
2016-04-25 English
FORM 6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, RedHill Biopharma Ltd., with the SEC. It includes a press release titled 'RedHill Biopharma Reports 2016 First Quarter Financial Results' and condensed interim unaudited financial information for the quarter ended March 31, 2016. Form 6-K is used by foreign private issuers to report material information between annual reports. The presence of quarterly financial results and interim financial information indicates this is an Interim / Quarterly Report. The document length is 2036 characters, which is relatively short but contains substantive financial data, not just an announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2016-04-20 English
FORM 6-K
Regulatory Filings Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, RedHill Biopharma Ltd., with the SEC. It includes a press release about the company's participation in a healthcare series event. The document is short (1907 characters) and primarily serves as a report of a press release rather than containing detailed financial data or comprehensive reporting. Form 6-K filings are typically used for current reports by foreign private issuers and often include announcements or updates rather than full financial reports. Given the length and content, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2016-04-19 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.